Optimi Health ships psilocybin capsules to Australia in third export
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street dips as spiking crude prices revive fears of inflation, rate hike
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
June 29, 2026 9:00 AM EDTOptimis 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.
The export marks Optimis third commercial shipment since launching the 5mg psilocybin capsules in September 2025.
VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the Company or... More
